| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 1995;25:343-349.)
© 1995 American Heart Association, Inc.
Articles |
Glucocorticoids Induce Angiotensin-Converting Enzyme Expression in Vascular Smooth Muscle
From the Cardiology Division, Department of Medicine (R.S.F., S.E., R.A.R.) and Department of Pathology (S.-Y.S., K.E.B.), Emory University, Atlanta, Ga; and the Cardiology Division, Department of Medicine (B.C.B.), University of Washington, Seattle.
Abstract Angiotensin-converting enzyme (ACE) activity plays a central role in vessel growth and remodeling as shown by the fact that ACE inhibitors reduce neointimal proliferation after rat carotid injury. To investigate the mechanisms that regulate smooth muscle cell ACE expression, we studied the effects of steroids on ACE activity and mRNA in cultured rat aortic smooth muscle cells. ACE activity was present at low levels independent of growth state. In response to the glucocorticoid dexamethasone (100 nmol/L for 72 hours), ACE activity (hydrolysis of [3H]benzoyl-Phe-Ala-Pro) increased 10.1±3.1-fold. The increase in activity occurred within 12 hours and peaked after 72 hours of treatment. The increase in ACE activity was specific for glucocorticoids and paralleled their potency (dexamethasone>hydrocortisone=prednisolone). Dexamethasone increased the steady-state level of ACE mRNA in a concentration-dependent manner (21.4±0.4-fold at 100 nmol/L for 72 hours). Dexamethasone stimulation of ACE expression appeared to be due to both increased transcription and stabilization of ACE enzyme mRNA. This was suggested by the finding that dexamethasone stimulated nuclear run-on expression of ACE mRNA by only threefold, in contrast to the 21-fold increase in steady-state mRNA. These findings establish that ACE is a dynamically regulated enzyme in rat aortic smooth muscle cells. In addition, the present findings suggest an important role for stress steroids in the vascular response to injury in vivo.
Key Words: steroids • dexamethasone • endothelium • angiotensin converting enzyme • muscle, smooth, vascular
This article has been cited by other articles:
 |
|
 |
|
  H. A. Shaltout, J. P. Figueroa, J. C. Rose, D. I. Diz, and M. C. Chappell Alterations in Circulatory and Renal Angiotensin-Converting Enzyme and Angiotensin-Converting Enzyme 2 in Fetal Programmed Hypertension Hypertension, February 1, 2009; 53(2): 404 - 408. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. C. Chung, L. Shimmin, S. Natarajan, C. L. Hanis, E. Boerwinkle, and J. E. Hixson Glucocorticoid Receptor Gene Variant in the 3' Untranslated Region Is Associated with Multiple Measures of Blood Pressure J. Clin. Endocrinol. Metab., January 1, 2009; 94(1): 268 - 276. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. R Walker Glucocorticoids and Cardiovascular Disease Eur. J. Endocrinol., November 1, 2007; 157(5): 545 - 559. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Adamzik, U. Frey, S. Sixt, L. Knemeyer, M. Beiderlinden, J. Peters, and W. Siffert ACE I/D but not AGT (-6)A/G polymorphism is a risk factor for mortality in ARDS Eur. Respir. J., March 1, 2007; 29(3): 482 - 488. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Lister, D. J. Autelitano, A. Jenkins, R. D. Hannan, and K. E. Sheppard Cross talk between corticosteroids and alpha-adrenergic signalling augments cardiomyocyte hypertrophy: A possible role for SGK1 Cardiovasc Res, June 1, 2006; 70(3): 555 - 565. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Kirton, F. L. Wilkinson, A. E. Canfield, and M. Y. Alexander Dexamethasone Downregulates Calcification-Inhibitor Molecules and Accelerates Osteogenic Differentiation of Vascular Pericytes: Implications for Vascular Calcification Circ. Res., May 26, 2006; 98(10): 1264 - 1272. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Horvath and A. Wanner Inhaled corticosteroids: effects on the airway vasculature in bronchial asthma Eur. Respir. J., January 1, 2006; 27(1): 172 - 187. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Girod and D. J. Brotman Does altered glucocorticoid homeostasis increase cardiovascular risk? Cardiovasc Res, November 1, 2004; 64(2): 217 - 226. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Hernandez Left ventricular hypertrophy after renal transplantation: new approach to a deadly disorder Nephrol. Dial. Transplant., July 1, 2004; 19(7): 1682 - 1686. [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. M. Barreto-Chaves, I. Aneas, and J. E. Krieger Glucocorticoid regulation of angiotensin-converting enzyme in primary culture of adult cardiac fibroblasts Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2001; 280(1): R25 - R32. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J Forhead, C. E Gillespie, and A. L Fowden Role of cortisol in the ontogenic control of pulmonary and renal angiotensin-converting enzyme in fetal sheep near term J. Physiol., July 15, 2000; 526(2): 409 - 416. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Lepailleur-Enouf, O. Valdenaire, M. Philippe, M. Jandrot-Perrus, and J.-B. Michel Thrombin induces endothelin expression in arterial smooth muscle cells Am J Physiol Heart Circ Physiol, May 1, 2000; 278(5): H1606 - H1612. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Tang, K. Both, and R. Taylor ACE inhibition and fibroblast growth factor in cultured human vascular smooth muscle Vascular Medicine, August 1, 1999; 4(3): 129 - 134. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Kurz, U. Hink, G. Nickenig, A. B. Borthayre, D. G. Harrison, and T. Munzel Evidence for a Causal Role of the Renin-Angiotensin System in Nitrate Tolerance Circulation, June 22, 1999; 99(24): 3181 - 3187. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Anwar, M. Schwab, L. Poston, and P. W. Nathanielsz Betamethasone-mediated vascular dysfunction and changes in hematological profile in the ovine fetus Am J Physiol Heart Circ Physiol, April 1, 1999; 276(4): H1137 - H1143. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E Ullian The role of corticosteroids in the regulation of vascular tone Cardiovasc Res, January 1, 1999; 41(1): 55 - 64. [Full Text] [PDF]
|
|
|
|
|
|
S. Hafizi, J. Wharton, K. Morgan, S. P. Allen, A. H. Chester, J. D. Catravas, J. M. Polak, and M. H. Yacoub Expression of Functional Angiotensin-Converting Enzyme and AT1 Receptors in Cultured Human Cardiac Fibroblasts Circulation, December 8, 1998; 98(23): 2553 - 2559. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Marumo, V. B. Schini-Kerth, R. P. Brandes, and R. Busse Glucocorticoids Inhibit Superoxide Anion Production and p22 Phox mRNA Expression in Human Aortic Smooth Muscle Cells Hypertension, December 1, 1998; 32(6): 1083 - 1088. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Christ and M. Wehling Cardiovascular steroid actions: swift swallows or sluggish snails? Cardiovasc Res, October 1, 1998; 40(1): 34 - 44. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Villard, A. Alonso, M. Agrapart, M. Challah, and F. Soubrier Induction of Angiotensin I-converting Enzyme Transcription by a Protein Kinase C-dependent Mechanism in Human Endothelial Cells J. Biol. Chem., September 25, 1998; 273(39): 25191 - 25197. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Boddi, L. Poggesi, M. Coppo, N. Zarone, S. Sacchi, C. Tania, and G. G. N. Serneri Human Vascular Renin-Angiotensin System and Its Functional Changes in Relation to Different Sodium Intakes Hypertension, March 1, 1998; 31(3): 836 - 842. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Challah, E. Villard, M. Philippe, A. Ribadeau-Dumas, B. Giraudeau, P. Janiak, J.-P. Vilaine, F. Soubrier, and J.-B. Michel Angiotensin I-Converting Enzyme Genotype Influences Arterial Response to Injury in Normotensive Rats Arterioscler Thromb Vasc Biol, February 1, 1998; 18(2): 235 - 243. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Bardy, R. Merval, J. Benessiano, J.-L. Samuel, and A. Tedgui Pressure and Angiotensin II Synergistically Induce Aortic Fibronectin Expression in Organ Culture Model of Rabbit Aorta: Evidence for a Pressure-Induced Tissue Renin-Angiotensin System Circ. Res., July 1, 1996; 79(1): 70 - 78. [Abstract] [Full Text]
|
|